Downstream processing of plasmid DNA for gene therapy and genetic vaccination

Chemical Engineering and Technology

Volumn 31, Issue 6, 2008, Pages 858-863

  Voß, Carsten ^a  

^a BIELEFELD UNIVERSITY   (Germany)

Author keywords

Cell disruption; Gene therapeutics; Plasmid DNA

Indexed keywords

CHEMOTHERAPY; CLONING; CUSTOMER SATISFACTION; DNA; GENE TRANSFER; GENETIC ENGINEERING; IMMUNIZATION; NUCLEIC ACIDS; ORGANIC ACIDS; PROBLEM SOLVING; QUALITY ASSURANCE; QUALITY FUNCTION DEPLOYMENT; SEPARATION; TOTAL QUALITY MANAGEMENT;

ANALYTICAL TECHNIQUES; CELL DISRUPTION; CLINICAL TRIALS; DOWNSTREAM PROCESSING; GENE THERAPEUTICS; GENE THERAPIES; GENETIC INFORMATION; GENETIC VACCINATION; HIGH-QUALITY; NON-VIRAL GENE DELIVERY; PLASMID DNA; SAFETY CONCERNS; VIRAL SYSTEMS;

GENES;

EID: 46049113889     PISSN: 09307516     EISSN: 15214125     Source Type: Journal    
DOI: 10.1002/ceat.200800069     Document Type: Review

References (70)

1. D. Geddes, E. Alton, Adv. Drug Deliv. Rev. 1998, 30 (1-3), 205.
2. A. Mountain, Trends Biotechnol. 2000, 18 (3), 119.
3. J. R. Mascola, G. J. Nabel, Curr. Opin. Immunol. 2001, 13 (4), 489.
4. J. W. Shiver et al., Nature 2002, 415 (6869), 331.
5. D. H. Barouch et al., Proc. Natl. Acad. Sci. U S A 2000, 97 (8), 4192.
6. D. H. Barouch et al., Science 2000, 290 (5491), 486.
7. M. L. Michel et al., Proc. Natl. Acad. Sci. U S A 1995, 92 (12), 5307.
8. M. E. Major et al., J. Virol. 1995, 69 (9), 5798.
9. S. G. Stolberg, N Y Times Mag. 1999, 136.
10. E. Check, Nature 2002, 420 (6912), 116.
11. J. A. Wolff et al., Science 1990, 247(4949 Pt 1), 1465.
12. J. Schorr et al., Ann. N Y Acad. Sci. 1995, 772, 271.
13. C. Voss et al., J. Biotechnol. 2003, 105 (3), 205.
14. C. Voss et al., J. Chem. Technol. Biotechnol. 2004, 79 (1), 57.
15. T. Schmidt, Dissertation, Universität Bielefeld 1998.
16. A. E. Carnes, C. P. Hodgson, J. A. Williams, Biotechnol. Appl. Biochem. 2006, 45 (Pt 3), 155.
17. M. S. Levy et al., Trends Biotechnol. 2000, 18 (7), 296.
18. J. Urthaler et al., J. Biotechnol. 2007, 128 (1), 132.
19. H. Hebel et al., Vaccine 2006, 24 (21), 4607.
20. C. Voss, T. Schmidt, M. Schleef, in DNA-Pharmaceuticals (Eds: M. Schleef), Wiley-VCH, Weinheim 2005.
21. C. Voss, Biotechnol. Annu. Rev. 2007, 13C, 201.
22. D. S. Holmes, M. Quigley, Anal. Biochem. 1981, 114 (1), 193.
23. K. O'Mahony et al., J. Biotechnol. 2005, 119(2), 118.
24. D. M. Prazeres et al., Trends Biotechnol. 1999, 17 (4), 169.
25. A. Eon-Duval, G. Burke, J. Chromatogr. B 2004, 804 (2), 327.
26. A. Ljunglöfet et al., J. Chromatogr. A 1999, 844 (1-2), 129.
27. EMEA, CPMP/410/01 rev 1, London 2001.
28. C. Voss, D. Lindau, E. Flaschel, Biotechnol. Prog. 2006, 22 (3), 737.
29. A. Eon-Duval, K. Gumbs, C. Ellett, Biotechnol. Bioeng. 2003, 83 (5), 544.
30. A. Eon-Duval et al., Anal. Biochem. 2003, 316 (1), 66.
31. R. J. Lander et al., Biotechnol. Bioeng. 2002, 79 (7), 776.
32. P. O. Wahlund et al., J. Chromatogr. B 2004, 807 (1), 121.
33. P. A. Albertsson, Biochim. Biophys. Acta 1965, 103, 1.
34. R. Ohlsson, C. C. Hentschel, J. G. Williams, Nucleic Acids Res. 1978, 5 (2), 583.
35. S. C. Ribeiro et al., Biotechnol. Bioeng. 2002, 78 (4), 376.
36. A. Frerix et al., Biotechnol. Appl. Biochem. 2005, 42 (Pt 1), 57.
37. A. Frerix et al., Biotechnol. Bioeng. 2007, 96 (1), 57.
38. T. A. Hatton, in Surfactant based separation processes (Eds: J. F. Scamehorn, J. H. Harwell), Marcel Dekker Inc., New York, Basel 1989.
39. S. H. Krishna et al., Adv. Biochem. Eng. Biotechnol. 2002, 75, 119.
40. V. E. Imre, P. L. Luisi, Biochem. Biophys. Res. Commun. 1982, 107 (2), 538.
41. M. Goto et al., J. Chem. Eng. Jpn. 1999, 32 (1), 123.
42. M. Goto, A. Momota, O. Tsutomu, J. Chem. Eng. Jpn. 2004, 37 (5), 662.
43. N. Streitner, C. Voss, E. Flaschel, J. Biotechnol. 2007, 131 (2), 188.
44. N. Streitner, C. Voß, E. Flaschel, Chem. Ing. Tech. 2008, eingereicht. DOI: 10.1002/cite.200800037
45. R. Lemmens et al., J. Chromatogr. B 2003, 784 (2), 291.
46. A. Strancar et al., Adv. Biochem. Eng. Biotechnol. 2002, 76, 49.
47. C. Viklund et al., Chem. Mater. 1996, 8 (3), 744.
48. C. Viklund et al., Biotechnol. Prog. 1997, 13 (5), 597. 49 V. I. Lozinsky et al., Trends Biotechnol. 2003, 21 (10), 445.
49. K. Branovic et al., J. Chromatogr. B 2004, 801 (2), 331.
50. J. Urthaler et al., J. Chromatogr. A 2005, 1065 (1), 93.
51. P. Kramberger et al., J. Virol. Methods 2004, 120 (1), 51.
52. L. M. Sandberg et al., J. Biotechnol. 2004, 109 (1-2), 193.
53. J. Porath, Protein Expr. Purif. 1992, 3 (4), 263.
54. R. Hahn, R. Schlegel, A. Jungbauer, J. Chromatogr. B 2003, 790 (1-2), 35.
55. T. Ito, C.L. Smith, C. R. Cantor, Proc. Natl. Acad. Sci. U S A 1992, 89 (2), 495.
56. T. Schluep, C. L. Cooney, Nucleic Acids Res. 1998, 26 (19), 4524.
57. T. Schluep, C. L. Cooney, Bioseparation 1999, 7 (6), 317.
58. M. D. Costioli et al., Biotechnol. Bioeng. 2003, 81 (5), 535.
59. J. Lundeberg, J. Wahlberg, M. Uhlen, Genet. Anal. Tech. Appl. 1990, 7 (3), 47.
60. A. Hasche, C. Voß, J. Chromatogr. A 2005, 1080 (1), 76.
61. J. Woodgate et al., Biotechnol. Bioeng. 2002, 79 (4), 450.
62. S. Ghose, G. M. Forde, N. K. Slater, Biotechnol. Prog. 2004, 20 (3), 841.
63. GM. Forde et al., Biotechnol. Bioeng. 2006, 95 (1), 67.
64. S. Balan et al., Biotechnol. Lett. 2003, 25 (13), 1111.
65. J. C. Murphy et al., Biotechnol. Prog. 2003, 19 (3), 982.
66. L. Tan et al., J. Chromatogr. A 2007, 1141 (2), 226.
67. J. Y. Fu et al., J. Mol. Recognit. 2006, 19 (4), 348.
68. T. Schmidt, K. Friehs, E. Flaschel, J. Biotechnol. 1996, 49 (1-3), 219.
69. T. Schmidt et al., Anal. Biochem. 1999, 274 (2), 235.
70. W. Walther et al., Anal. Biochem. 2003, 318 (2), 230.